Kangmei Pharma | 600518 - PE Price to Earnings

Stock Price
1.60
Daily Change
-0.01 -0.62%
Monthly
-8.57%
Yearly
-20.40%
Q2 Forecast
1.59

Kangmei Pharma reported 3.15K in PE Price to Earnings for its fiscal quarter ending in June of 2025.





Pe Change Date
Akebia Therapeutics 1.63K 1.6K Dec/2025
Cspc Pharmaceutical 24.4 1.13 Dec/2025
Dianthus Therapeutics 3.8 1.53 Sep/2024
Genomma Lab Internacional 11 0.16 Mar/2026
Hypermarcas 12.09 3.91 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 19.37 7.21 Mar/2026
Jiangsu Hengrui 46.42 5.23 Mar/2026
Kangmei Pharma 3.15K 624.19 Jun/2025
Moderna 27.22 14.51 Jun/2023
Organon & Co 3.75 0.87 Dec/2025
Revvity 30.79 19.08 Mar/2026
Sh Fosun Pharma 18.98 5.93 Dec/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Viatris 14.61 4.21 Mar/2026
Wuxi Apptec 14.84 1.23 Mar/2026
Zz Pientze Pharmaceu 47.68 1.35 Mar/2026